Page last updated: 2024-08-18

1,4-naphthoquinone and Angiogenesis, Pathologic

1,4-naphthoquinone has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayama, N; Kimachi, T; Murota, H; Nishiuchi, A; Ogata, T; Sakanaka, M; Shinya, T; Takahashi, S; Toda, KI1
Kayashima, T; Matsubara, K; Mizushina, Y; Mori, M; Yoshida, H1

Other Studies

2 other study(ies) available for 1,4-naphthoquinone and Angiogenesis, Pathologic

ArticleYear
Inhibition of angiogenesis and tumor growth by a novel 1,4-naphthoquinone derivative.
    Drug development research, 2019, Volume: 80, Issue:3

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Cell Line; Cell Movement; Cell Proliferation; Cell Survival; Endothelial Cells; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Naphthoquinones; Neoplasms; Neovascularization, Pathologic; Vascular Endothelial Growth Factor Receptor-2

2019
1,4-Naphthoquinone is a potent inhibitor of human cancer cell growth and angiogenesis.
    Cancer letters, 2009, Jun-08, Volume: 278, Issue:1

    Topics: Animals; Antineoplastic Agents; Cell Division; Cell Line, Tumor; Chemotaxis; Colonic Neoplasms; Endothelium, Vascular; Femoral Artery; HeLa Cells; Humans; Male; Naphthoquinones; Neovascularization, Pathologic; Rats; Rats, Wistar; Umbilical Veins

2009